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~ullous pemphigoid (BP) is an autoimmune skin disease that 
IS c~aracterized by the presence of subepidermal blisters re-
sulting from a disruption of the adhesive interactions be-
tween basal keratinocytes and the cutaneous basement mem-
brane. Autoantibodies from patients suffering from this 
disorder recognize two epidermal antigens, BP180 and 
BP230, both of which have been localized to the hemides-
rn~some, a transmembrane structure of stratified, squamous 
epithelia that functions in cell-matrix adhesion. In the 
present study we report the primary structural analysis of 
BP180 based on the sequence of a series of overlapping 
cD.NA clones encompassing 4,669 bases of the BP1 80 tran-
scnpt. A polymerase chain reaction-based protocol was used 
to confirm the contiguity of the cDNA segments. This 
cloned portion of the BP180 transcript was found to contain 
on~ long open reading frame (ORF) 4,596 bases in length. 
!hls ORF encodes a polypeptide of155,000 Daltons with an 
Isoelectric point of 9.7. The carboxyl-terminal half of 
BP180, a stretch of 916 amino acids, consists of 15 collagen 
dornains of variable length (15 to 242 amino acids) that are 
separated from one another by short stretches of non-colla-
gen sequences. Located 76 amino acids upstream of the col-
lagenous region is a putative transmembrane domain, a struc-
tural feature that distinguishes BP180 from all of the 
well-characterized members of the collagen family. This 
membrane-spanning domain is predicted to function as a 
signal-anchor sequence, directing the C-terminal collage-
nous segment of this protein to the exterior of the cell. The 
putative intracellular domain is highly basic with an isoelec-
tric point of 10.37. This molecular analysis predicts that the 
BP180 antigen is an integral membrane protein of the hemi-
desmosome that contains a long extracellular collagenous 
tail. This combination of structural features suggests that 
BP180 may function as a cell-matrix adhesion molecule, 
with the collagenous region acting as a potential site of inter-
action with basement membrane components. Autoanti-
body-mediated disruption of such an adhesive interaction 
may playa critical role in the development of sub-epidermal 
blisters in BP patients. ] Invest Dermatol 99:243 -250, 1992 
--------------------------------------------------------------------------------------------------------
T he clinico-pathologic features of Bullous Pemphigoid (BP), which were first described by Lever in 1952 [1], include tense, sub-epidermal bullae usually associated with an inflammatory infiltrate. Jordon and co-. workers [2,3]' using immunofluorescence (IF) tech-
niques, demonstrated the presence of circulating and tissue-bound 
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anti-basement membrane zone (BMZ) autoantibodies in BP pa-
tients. The antigenic targets of the circulating BP autoantibodies 
were ultrastructurally localized to the epidermal hemidesmosome 
[4-7], a membrane-spanning cellular structure thought to be an 
essential component of the dermal-epidermal adhesion system. 
Electron microscopic studies have shown BP blister formation is 
associated with a fragmentation and disappearance of both basal 
lamina and hemidesmosomal structures [8,9]. Taken together, these 
observations suggest that the BP humoral autoimmune response 
directed against a hemidesmosomal antigen may playa key role in 
the pathogenesis of this blistering skin disorder. It is important to 
note, however, that direct evidence of the pathogenicity of these 
anti-hemidesmosomal autoantibodies is lacking. 
Immunoblot and immunoprecipitation analyses have demon-
strated that two large epidermal folypeptides, BP230 and BP180, 
are the major antigenic targets 0 BP autoantibodies [10-12]. Re-
cent studies dealing with the characterization of these autoantigens 
have employed a molecular genetic approach involving the identifi-
cation ofBP antigen eDNA clones from human and mouse keratin-
ocyte eDNA expression libraries with the use ofBP autoantibodies 
[13 -16]. These molecular analyses have resolved the question con-
cerning the biosynthetic relationship between these polypeptides, 
demonstrating that BP180 and BP230 are the products of distinct 
and unrelated genes . Complementary DNA clones corresponding 
to these two antigens hybridized with distinct epidermal RNA tran-
scripts and exhibited no cross-hybridization [15]. Human or rabbit 
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Map of BP180 eDNA Clones 
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Figure L A map representing the sizes and relative positions of the BP180 
cDNA clones. These cDNA clones were isolated from two independent 
human keratinocyte libraries as described in Materials atld Methods. The first 
BP180 clone to be isolated, clone 22-A, was identified by antibody screening 
using a BP serum. Overlapping cDNA clones, represented by the bars, were 
subsequently identified by sequential nucleic acid screening. Arrows, posi-
tions and the 5' to 3' orientation of the oligonucleotide primers (18-mers) 
used in the peR analysis presented in Fig 2. The lengths of the arrows are not 
representative of the sizes of the primers. 
antibodies against cloned epitopes were shown to exhibit no cross-
reactivity between BP230 and BPIBO [15]. Chromosomal mapping 
studies localized the BP230 gene to the short arm of chromosome 6, 
locus 6pl1-'12 [17] and the BPIBO gene to the long arm of chro-
mosome 10, locus 10q24.3 [lB] . Finally, comparison of the full-
length BP230 sequence [19] with the BPIBO sequence presented in 
this report has failed to show any significant similarities. 
Ultrastructural localization studies using either rabbit antisera or 
human autoantibody preparations specifically directed against one 
or the other of these two m~or BP antigens have shown that both 
proteins are components of the epidermal hemidesmosome 
l15,16,20,21] . Both proteins appear to have intracellular domains 
that are restricted to the hemidesmosomal plaque. Other data have 
suggested that BP1BO may, in addition, have an extracellular do-
main [22]. The present report provides primary structural evidence 
that BPIBO is a transmembrane protein with a predicted type II 
orientation-the C-terminus positioned externally. The C-termi-
nal ectodomain consists of a series of collagen triple helical domains 
which may function in cell-matrix interactions. 
MATERIALS AND METHODS 
Isolation and Characterization ofBP180 cDNA Clones As 
described in a previous report [15]' a high-titer BP serum, BP-R1, 
was used to identify a 1.0-kb BPIBO cDNA clone, ABP1BO-22A, 
from an oligo dT -primed, human keratinocyte Agtll cDNA library 
(Clontech Laboratories, Palo Alto, CAl. A series of overlapping 
BPIBO cDNA clones (Fig 1) were isolated from the library de-
scribed above (clones 12-Z and 7-Y) , or from a random-primed, 
human keratinocyte Agtll cDNA library (Clontech Laboratories, 
Palo Alto, CA)(clones BB , 19-C, 10-D, 25-E, 261-G, and 262-F) by 
sequential screening with cRNA probes. 
DNA Subcloning and Sequence Analysis Two methods were 
used for the subcloning ofBP180 cDNA into a plasmid vector. The 
first method involved the conventional ligation of the EcoRI inserts 
of the Agtll-BP180 clones into the EcoRI site of the pBluescript 
IISK+ vector (Stratagene, La Jolla, CAl. The second method in-
volved polymerase chain reaction (PCR) [23] amplification of a 
segment of the BPIBO cDNA insert using a combination of one 
BP1BO-specific primer and one Agt11 vector primer (forward or 
reverse). The PCR product was subsequently ligated into the clon-
ing site of pCR- l 000 using the T A cloning kit (Invitrogen, San 
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Diego, CAl. The cDNA inserts were then analyzed according to the 
double-stranded DNA sequencing procedure of Chen and Seeburg 
[24], which is a modification of the dideoxy method of Sanger et al 
[25]. A series of oligonucleotide sequencing primers were synthe-
sized either by the Protein and Nucleic Acid Shared Facility at the 
Medical College of Wisconsin, or by Operon Technologies, Inc., 
Alameda, CA. The sequence data were analyzed using the Genetics 
Computer Group (GCG) sequence analysis software package [26]. 
Homology searches were run against the GenBank and EMBL nu-
cleotide sequence databases and the Swiss protein sequence database. 
PolYInerase Chain Reaction PCR [23] was used in the amplifi-
cation of BPIBO cDNA to aid in the subcloning of these DN~ 
segments from the Agtll bacteriophage vector to a bacterial plasml~ 
vector and to verify that the series ofBP180 cDNA clones presente 
in this report is derived from a single human keratinocyte transcnpt. 
For subcloning purposes, the PCR reaction mixture consisted of the 
following components: BP180-positive Agtll bacteriophage sus-
pensions from a primary library screen [approximately 4 X 105 pfu 
in 2 J.t! of SM solution (100 mM NaCI, B mM MgS04' 0.01% 
gelatin, 50 mM Tris, pH 7.5)],20 ng of either the Agtl1 forward Of 
reverse primer (Promega Corp., Madison, WI), 20 ng of a 
BPIBO-specific oligodeoxynucleotide (1B-mer) primer, 100,uM of 
each deoxynucleotide, 1 unit of Taq DNA polymerase and Taq 
polymerase buffer (enzyme and 10 X buffer from Promega Corp·, 
Madison, WI), with a final volume of 50 J.lL Each PCR reactlon 
mixture was overlaid with 70 J.lI of mineral oil and subjected to 30 
cycles of PCR (94°C, 2 min, 4BoC, 2 min, 72°C, 1.5 min) using a 
Coy Model 60 tempcycler (Coy Corp., Grass Lake, MI) . The peR 
products were fractionated by agarose gel electrophoresis and visual-
ized by ethidium bromide staining. To verify the contiguity of the 
BPIBO cDNA clones shown in Fig 1, combinations ofBPlBO-spe-
cific primers (as described in the legend of Fig 2) were use~ to 
amplify segments of BPIBO cDNA from a Agtl1 human keratlI1°-
cyte library (a generous gift from Dr. J. Uitto, Philadelphia, p~). 
This library was constructed independent of the two cDNA Iibranes 
from which the set of overlapping BPIBO clones were isolated. The 
PCR products were characterized as described above. 
Collagenase Digestion of BP180 froIn HUInan Epidermal 
Extracts Epidermal extracts were treated with collagenase and 
analyzed according to a modification of the protocol described by 
Yoshiike et al [27]. Epidermis obtained by keratectomy (6 cm2) waS 
ground to a powder with a mortar and pestle under liquid nitrog~n . 
The tissue fragments were extracted in 1 ml of a solution contalI11~g 
150 mM NaCI, 1 mM EGTA, 1 mM dithiothreitol, 62.5 ruM: Trl~ 
pH 7.4, 0.5 mM PMSF, 7 J.lg/mlleupeptin, 7 J.lg/ml antipalI1,.l 
I1g/ml pepstatin A, and 1411g/ml chymostatin. After brief sonlcad tion, 25-J.lI aliquots of the epidermal suspension were pelleted ::M 
resuspended in 25 J.l1 ofTBSC [0.2 M NaCl, 10 mM CaCI2 , 2~ . 
Tris, pH 7.4, 0.5 mM PMSF, 7 J.lg/mlleupeptin, 7 J.lg/ml antlpaln, 
14 J.lg/ml pepstatin A, and 14 J.lg/ml chymostatin], with or witho~: 
1 BTC unit of collagenase from Clostridium histolyticum (Forrn II , 
Advance Biofactures Corp., Lynbrook, NY). After incubation at 
37°C for various amounts of time, as indicated in the tex~, th~ 
reactions were stopped by incubating at 100°C for 5 minutes 1111 
SDS gel sample buffer, then assayed by SDS-PAGE and i~rnUf 
noblotting. A variety of controls were run to test the specifiCity 0 
the collagenase preparation. PAGE analysis of the epiderrnal e):-
tracts revealed no evidence that any of the major Coomassie Blue: 
staining proteins were degraded by the collagenase treatment. yn 
munoblot analysis demonstrated that the BP230 epidermal antlgen 
(a non-collagenous protein) was not degraded by the collagenase~ 
Aliquots of calf skin collagen (type I, Sigma, St. Louis, MO), bovln 
muscle myosin (Sigma, St. Louis, MO) and bovine serum alburnl~ 
(BSA; ICN ImmunoBiologicals, Lisle, IL) were incubated for 2 h a_ 
37°C with 1 BTC unit of collagenase. PAGE analysis revealed cornd plete digestion of the calf skin collagen, whereas the myos1I1f ar e 
BSA showed no detectable degradation. EDT A inhibition 0 t~_ 
collagenase dig~stions provided additional eV.idence that the :ar-
served degradation ofBPlBO was due to the actIOn of the well-c 
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acterized Ca++ -dependent bacterial collagenase, and not to contami-
nating proteolytic ac tivity. 
SDS-Polyacrylamide Gel Electrophoresis (SDS-PA~E) and 
hnmunoblotting Procedures The SDS-PAGE and Imm~no­
blotting procedures performed in this study .were descnbed 
previously [15]' Briefly, protein extracts we~e fractIonated bX SDS-
PAGE according to the protocol of Laemmh [28]: The fractIOnated 
proteins were electrophoretically transferred to mtr?ce~lulose'paper 
[29] and probed with a primary antibody diluted as.mdlcated m 1 X 
PTX solution [0.01 M phosphate, fH 7.5, 0.2% Tnton X-I00, ?15 
M NaCI , 1 mM EGTA, 4% BSA . Primary antibody preparations 
used in this study included two BP sera, BP-Rl and B~-Cl, and a 
rabbit antiserum, R22-31 [15], directed against the fusIOn protem 
encoded by clone ABP180-22A. Boun~ antibodies were ~etected 
USIng 1251 Staphylococcus aureus protem A. Im~unoreactive pro-
tem bands were visualized by autoradiography usmg Kodak XAR5 
film with DuPont Lightning Plus intensifying screens. 
RESULTS 
Isolation and Characterization ofBP180 cDNA Clones The 
initial BP180 cDNA clone (clone 22-A) was identified on the ba~is 
of reactivity of its product with BP autoantibodies [15]. Sequential 
nucleotide screening of two independent human .keratmocyte 
cDNA libraries has now led to the isolation of a set of overlappmg 
cDNA clones spanning 4,669 bases of the BP180 ~ranscript . ~igure 
1 shows the alignment of these clones and the posmon and onenta-
tlon of the oligonucleotide primers used for sequencmg. 
Polymerase chain reaction (PCR) analysis was used to con~rm 
the contiguity of the cDNA clones shown in Fig ~. Overlappmg 
segments spanning 4,386 bp of the BP180 transcnpt ~ere PCR-
amplified from a human keratinocyte cDNA library usmg BP180 
specific primers. The library that was used as the PCR template :vas 
unrelated to the libraries from which the BP180 clones were ISO-
lated. Figure 2 shows the results of this analysis. In each case a PCR 
product of the predicted size was obtained. 
Sequence Analysis The entire length of the negative strand and 
90% of the positive strand of the cloned porti.on ?f BP180 was 
sequenced by the dideoxynucleotide chain termmatJo?, procedure. 
Ali G-C - rich regions that exhibited co~pr~ssio~ artifacts on the 
sequencing gels were sequenced by substltutmg either dlTP o.r. 7-
deaza-dGTP in place of dGTP. The identification of the positive 
and negative strands was based on previously reported ~orthern 
blot .analyses using strand-specific cRNA probes l~5]. TIllS cloned 
POrtion of the BP 180 transcript was found to contam o.ne long open 
readmg frame (ORF) in the sense orientation extendmg from n~­
c1eotide 1 to the in-frame stop codon at position 4597 -459? This 
ORF encodes a polypeptide with a calculated molecular weight of 
1.55,000 daltons and an isoelectric point of 9. 7. The BP180 nucleo-
tide and deduced amino acid sequence is shown in Fig 3. 
An analysis of the deduced amino acid sequence of BP180 re-
vealed several interesting structural features. The C-terminal half of 
this polypeptide, a stretch of916 amino acids, is made up prima:ily 
of ta.ndem repeats of the tripeptide, Glycine-X-Y, with a very hlg? 
hrohne Content at the X and Y positions. Thi.s ~eque~ce pattern IS 
.Ighly predictive of a protein domain that participates m the forma-~on of a colJagen triple helix. Interspersed within this lo~g colJage-
ous region are 15 stretches of non-collagen sequence, with lengths ~6 . ( . . 
. to 58 residues, demarcating 15 collagen domams rangmg ~n ~ze frOm 15 to 242 amino acids; designated by the shaded area~ m 
. Ig 3) . Seventy-six amino acids upstream of the collagenous regIOn ~ a P~tative membrane-spanning . domain (position 502 - 524), 
hlch IS flanked by an upstream Iysme and two downstream glut~­
l1J.ate residues . Upstream of this potential transmembrane domam ~~e four closely sp~ced cysteine res.idues and a 25-resi~ue stretch 
35ntam11lg 15 glycmes and five sennes. Located at position 261-
1.8 are four tandemly arranged 24 residue repeat sequences. The 
a I~nrnent of these repeats is shown in Fig 4. The stretch f~om 
al1J.lno acid 1 to 229 of this cloned portion of BP180 has a particu-
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Figure 2. Polymerase chain reaction analysis. This analysis was performed 
to confirm the contiguity of the series of overlapping BP180 cDNA clones 
that are represented in Fig 1. Synthetic oligonucleotide prim~rs based on the 
sequence obtained from the BP180 clones were used to at;'plIf'y segments of 
the BP180 transcript from a human keratmocyte cDNAltbrary. The ltbrary 
that was used as the peR template is not related to the ltbrarles from which 
the BP180 clones were isolated. The peR reaction products are shown in 
lanes 2, 4, 6, 8, and 10 and the corresponding "no template" controls are 
shown in latles 3, 5, 7, 9, and 11 . The peR primers (designated by the 
nucleotide number of the primer's 5' terminus and by the suffix "neg" or 
"pos" indicating the negative or positive strand, respectively) were used in 
the following combinations: 37pos and 707neg (lan es 2 and 3); 538pos and 
1701neg (Iatl es 4 and 5); 1645pos and 2824neg (Ialm 6 and 7); 2807pos and 
3834neg (Iall es 8 and 9); 3690pos and 4423neg (Ialles 10 and 11). The 
predicted sizes of the peR products are 670 bp,lalle 2; 1163 bp, lalle 4; 1179 
bp, lane 6; 1027 bp, lalle 8; 733 bp, lalle to. On the left of the gel are the 
lengths (in bp) of the DNA Slze markers (1 kb ladder, BRL) that were run 111 
latles 1 and 12. 
larly high isoelectric point of 11 .34. A schematic representation of 
the structural domain organization of BP180 is shown in Fig 5. 
The BP180 sequence was compared with the GenBank nucleo-
tide sequence database (release 69) and the Swiss protein sequence 
database (release 19). As expected, homologies were observed with 
all members of the collagen family. Human coll agens al(I), al(III), 
a2(IV), a2(XI), and a1(XI) showed similarities of 56%,55%,53%, 
53%, and 52%, respectively, over stretches of approximately 1100 
amino acids. A particularly high degree of sequence homology, at 
both the nucleotide and amino acid levels, was detected between 
BP180 and a chick cornea collagen recently reported by Marchant et 
al [30] . The amino acid sequence alignment of these two po!ype~­
tides, shown in Fig 6, reveals identical residues at 64% of the POSI-
tions with an additional 14% of the positions containing conserva-
tive substitutions. In addition to the overall sequence similarities 
between these two polypeptides, there is a striking conservation in 
the sizes and positions of their collagen domains (indicated by the 
shaded boxes in Fig 6) . Comparison of the BP180 cDN A sequence 
with that of the previously published BP230 cDNA [1 9] revealed 
no significant homology at either the nucleotide or amino acid 
levels . 
Collagenase Digestions To furth er document the existence of a 
collagenous structure within the BP180 epidermal autoantigen, a 
human skin extract was digested with bacterial collagenase under 
various conditions and analyzed by SDS-PAGE and immunoblot-
ting with a BP serum, BP-Rl, and a rabbit antiserum, R22-31, 
directed against the figal-BPl80A fusion protein [15]. At time zero 
the epidermal extract was shown to contain BP180 as a 180-kD 
antigen recognized by serum BP-Rl (Fig 7, lalle 1). Lanes 2, 3, and 4 
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CCGCTGCAAATTTCTAGAAGAAAACATCAGGAGAAGAAAGAGAGAGGGGGATTTATTCAAAGTTGTTTCCAATTCCTTCAAAACCTCAAACCAGGTGGCT 
PLQISRRKHQEKKERGGFIQSCFQFLQNLKPGGY 
ATGGTATGGATGTAACCAAGAAAAACAAACGAGATGGAACTGAAGTCACTGAGAGAATTGTCACTGAAACAGTAACCACAAGACTTACATCCTTACCACC 
G M D V T K K N K R D GTE V T E R I V T E T V T T R L T 5 L P P 
AAAAGGCGGGACCAGCAATGGCTATGCTAAAACAGCCTCTCTTGGTGGAGGGAGCCGGCTGGAGAAACAAAGCCTGACTCATGGCAGCAGCGGCTACATA 
KGGTSNGYAKTAS LGGG SRL EKQSLTHGSSGYI 
AACTCAACTGGAAGCACACGAGGCCATGCCTCCACCTCTAGTTACAGGAGGGCTCACTCACCTGCCTCCACTCTGCCCAACTCCCCAGGCTCAACCTTTG 
NSTGSTR GHASTSSYRRAHSPASTLPNSPGSTFE 
AAAGGAAAACTCACGTTACCCGCCATGCGTATGAAGGGAGCTCCAGTGGCAACTCTTCTCCGGAGTACCCTCGGAAGGAATTTGCATCTTCTTCAACCAG 
RKTHV TRHAYEGSSSGNSSPEYPRKEFASSSTR 
AGGACGGAGTCAAACACGAGAGAGTGAAATTCGAGTTCGACTGCAGAGTGCGTCCCCATCCACCCGATGGACAGAATTGGATGATGTTAAGCGTTTGCTC 
G R S Q T RES E I R V R L Q S ASP S TRW TEL D D V K R L L 
AAGGGGAGTCGATCGGCAAGTGTGAGCCCCACCCGGAATTCCTCCAACACACTCCCCATCCCCAAGAAAGGCACTGTGGAGACCAAAATTGTGACAGCGA 
KGSRSASVSPTRNSSNTLPIPKKGTVETKIVTAS 
GCTCCCAGTCGGTGTCAGGCACCTACGATGCAACGATCCTGGATGCCAACCTTCCCTCCCATGTGTGGTCCTCCACCCTGCCCGCGGGGTCCTCCATGGG 
SQSVSGTYDAT ILDANLPSHVWSSTLPAGSSMG 
GACCTATCACAACAACATGACAACCCAGAGCTCATCCCTCCTCAACACCAATGCCTACTCTGCGGGATCAGTCTTCGGAGTTCCAAACAACATGGCGTCC 
T Y H N N M T T Q S S S L L N T N A ' Y SAG 5 V F G V P N N MAS 
TGCTCACCCACTTTGCACCCTGGACTCAGCACATCCTCCTCAGTGTTTGGCATGCAGAACAATCTGGCCCCCAGCTTGACCACCCTGTCCCATGGCACCA 
C 5 P T L H P G L 5 T S 5 5 V F G M Q N N LAP 5 L TTL S H G T T 
CCACCACTTCCACAGCATATGGGGTGAAGAAAAACATGCCCCAGAGTCCTGCGGCTGTGAACACTGGCGTTTCCACCTCCGCCGCCTGCACCACAAGTGT 
TTSTAYGVKKNMPQSPAAVNTGVSTSAACTTSV 
GCAGAGCGATGACCTTTTGCACAAGGACTGCAAGTTCCTGATCCTAGAGAAAGACAACACACCTGCTAAGAAGGAGATGGAGCTGCTCATCATGACCAAG 
QSDDLLHKDCKFLILEKDNTPAKKEMELLIMTK 
GACAGCGGGAAGGTCTTTACAGCCTCCCCTGCCAGCATCGCTGCAACTTCTTTTTCAGAAGACACCCTAAAAAAAGAAAAGCAAGCTGCCTACAATGCTG 
DSG KVFTASPAS IAATSFSEDTLKKEKQAAYNAD 
ACTCAGGCCTAAAAGCCGAAGCTAATGGAGACCTGAAGACTGTGTCCACAAAGGGCAAGACCACCACTGCAGATATCCACAGCTACAGCAGCAGTGGTGG 
5 G L K A E A N G D L K T V 5 T K G K T T TAD I H S Y 5 SSG G 
TGGTGGCAGTGGAGGAGGTGGCGGTGTTGGTGGCGCTGGCGGCGGCCCTTGGGGACCAGCGCCAGCCTGGTGCCCCTGCGGCTCCTGCTGCAGCTGGTGG 
G G 5 G G G G G V G GAG G G P W G PAP A W C P C G 5 C C 5 W W 
AAGTGGCTGCTGGGCCTGCTGCTCACCTGGCTGCTACTCCTGGGGCTGCTCTTCGGCCTCATTGCTCTGGCGGAGGAGGTGAGGAAGCTGAAGGCGCGTG 
K W L L G L L L T W L L L L G L L F G L I A L A E E V R K L K A R V 
TGGATGAGCTGGAGAGGATCAGGAGGAGCATACTGCCCTATGGGGACAGCATGGATAGAATAGAAAAGGACCGCCTCCAGGGCATGGCACCCGCGGCGGG 
DEL E R I R R 5 I L P Y G D 5 M D R I E K D R L Q G MAP A A G 
AGCAGACCTGGACAAAATTGGGCTGCACAGTGACAGCCAGGAGGAGCTCTGGATGTTCGTGAGGAAGAAGCTAATGATGGAACAGGAAAATGGAAATCTC 
A D L D K I G L H 5 D 5 Q EEL W M F V R K K L M M E Q ENG N L 
CGAGGAAGCCCTGGCCCTAAAGGTGACATGGGAAGTCCAGGCCCTAAAGGAGATCGAGGGTTCCCTGGGACTCCAGGTATCCCTGGGCCCTTGGGCCACC 
R G' S P G P K G D M G S p ' G .... p K G D R G F " P G •••• T .< P G I •• p ' . G . p ::1. G "'i! . p 
CAGGTCCACAAGGACCAAAGGGTCAAAAAGGCAGCGTGGGAGATCCTGGCATGGAAGGCCCCATGGGCCAGAGAGGGCGAGAAGGCCCCATGGGACCTCG 
G P Q G P K G Q K G S ' V "' G " O " p ' G MEG ' P M···· G · QR · G R ' E G P " ~j" ' G "" p " ' lf 
TGGTGAGGCAGGGCCTCCTGGATCTGGAGAGAAAGGGGAAAGAGGGGCTGCTGGTGAACCAGGTCCTCATGGCCCACCTGGTGTCCCAGGTTCTGTGGGT 
G E A G P P G S G E K G ERG A AGE P G P H G P P G V P G 5 V G 
CCCAAAGGTTCCAGCGGCTCTCCTGGCCCACAGGGCCCTCCAGGTCCTGTAGGTCTCCAAGGGCTCCGAGGTGAAGTAGGACTTCCTGGTGTCAAAGGTG 
~ K G 5 S G S P G P Q G P P G P V G L Q G L R G E V G LPG V K G D 
'ACAAAGGACCAATGGGACCACCAGGACCCAAAGGTGACCAGGGTGAGAAAGGACCTCGAGGCCTCACAGGCGAGCCTGGCATGAGAGGTTTGCCTGGTGC 
K G P M G P P G P K G D Q G E K G P R G LTG E P G M R G LPG . A 
TG TTGGTGAGCCCGGGGCTAAAGGAGCAATGGGTCCTGCTGGCCCAGACGGACACCAAGGCCCAAGAGGTGAACAAGGTCTTACTGGGATGCCTGGAATC 
VGEPGAKGAMGPAGPDGHQG PRGEQGLTGMP GI 
CGTGGCCCACCAGGACCTTCTGGAGACCCAGGAAAGCCAGGTCTCACAGGACCCCAGGGACCTCAGGGACTTCCCGGTACCCCTGGCCGACCAGGAATAA 
RGPPGPSGDPGKPGLTGPQGPQGLPGTPGRPGIK 
AAGGTGAACCAGGAGCTCCAGGCAAGATCGTGACTTCGGAGGGGTCATCGATGCTCACTGTCCCAGGCCCCCCAGGACCTCCTGGAGCCATGGGACCCCC 
GEPGAPGKIVTSEGSSMLTVPGPPGPPGAMGPP 
AGGACCTCCAGGTGCCCCAGGCCCTGCCGGCCCAGCTGGTCTCCCAGGACATCAAGAAGTTCTTAATTTACAAGGTCCCCCAGGCCCACCCGGCCCACGT 
GPPGAPGPAGPAGLPGHQEVLNLQGPPGPPGPR 
GGGCCACCAGGGCCTTCCATTCCAGGCCCACCAGGACCCCGAGGCCCACCAGGGGAGGGTTTGCCAGGCCCACCAGGCCCACCAGGATCGTTCCTGTCCA 
G P P G psI P G P P G P RG P P G E G L . p ••. i ci. !' .... p G . P .• > PO •.. S.<:. F L 5 N 
ACTCAGAAACCTTCCTCTTCGGCCCCCCAGGCCCACCTGGCCCCCCAGGTCCCAAGGGAGACCAAGGTCCCCCAGGCCCCAGAGGACACCAAGGCGAGCA 
5 E T F L F ; G P P G P P G < P P G P K G D ' Q G:. "P ••.•• P G p " R G H ··.· Q .•••• dE Q 
AGGCCTCCCAGGTTTCTCAACCTCAGGGTCCAGTTCTTTCGGACTCAACCTTCAGGGACCACCAGGCCCACCTGGCCCCCAGGGA'CCAAAAGGTGACAAA 
G LPG F S T 5 G 5 5 5 F G L N L Q G P •.• p .G '. p ••• P G P Q .0 .... p. . K' .G. D K 
GGTGATCCGGGTGTTCCAGGGGCTCTTGGCATTCCTAGTGGTCCTTCTGAAGGGGGATCATCAAGTACCATGTACGTGTCAGGCCCGCCAGGGCCCCCTG 
G D .•. P G.<V . p G A. L G ...• r •• J;' 5 G. 1.' s . EGG 5 SST M Y V S ' G . i ~ •. :p J ~ · P ' P G 
GGCCCCCTGGGCCTCCGGGCTCTATCAGCAGCTCTGGCCAGGACATTCAGCAGTACATCTCTGAGTACATGCAGAGTGACAGTATTAGATCTTACCTATC 
P . P G p ' p G 5 I 5 SSG Q E I Q Q Y I S E Y M Q 5 D 5 IRS Y L 5 
CGGAGTTCAGGGTCCCCCAGGCCCACCTGGTCCCCCAGGACCTGTCACCACCATCACAGGCGAGACTTTCGACTACTCAGAGCTGGCAAGCCACGTTGTG 
G V Q G P P G P P G P p ' G p' V TTl T GET F D Y 5 E LAS H V V 
AGCTACTTACGGACTTCGGGGTACGGTGTCAGCTTGTTCTCGTCCTCCATCTCTTCTGAAGACATCCTGGCTGTGCTGCAGCGGGATGACGTGCGTCAGT 
SYLRTSGYGVSLFSSSISSE DILAVLQRDDVRQY 
ACCTACGTCAGTACTTGATGGGCCCTCGGGGTCCGCCAGGGCCACCAGGAGCCAGTGGAGATGGGTCCCTCCTGTCTTTGGACTATGCAGAGCTGAGTAG 
L R Q Y L M G P R G P P G''' p P GAS G D" :G0 S L L 5 L D Y A E L 5 5 
TCGCATTCTCAGCTACATGTCGAGTTCTGGGATCAGCATTGGGCTTCCTGGTCCCCCGGGGCCCCCTGGCTTGCCGGGAACCTCCTATGAGGAGCTCCTC 
R I L 5 Y M 5 SSG I 5 I G LPG P P G P + P G LPG T S Y EEL L 
TCCTTGCTGCGAGGGTCTGAATTCAGAGGCATCGTTGGACCCCCAGGTCCCCCGGGTCCACCAGGGATCCCAGGCAATGTGTGGTCCAGCATCAGCGTGG 
SLLRGSEFRGI VGPPGPPGPPGIPGNVWSSI SVE 
AGGACCTCTCGTCTTACTTACATACTGCCGGCTTGTCATTCATCCCAGGCCCTCCAGGACCTCCTGGTCCCCCAGGGCCTCGAGGGCCCCCGGGTGTCTC 
D L S 5 Y L H TAG L S F I P G P P G P P G P P G P R G P P G V S 
AGGAGCCCTGGCAACCTATGCAGCTGAAAACAGCGACAGCTTCCGGAGCGAGCTGATCAGCTACCTCACAAGTCCTGATGTGCGCAGCTTCATTGTTGGC 
GAL A T Y A A ENS D S FRS ELI 5 Y L T 5 P D V R 5 F I V G 
CCCCCAGGCCCTCCTGGGCCGCAGGGACCCCCTGGGGACAGCCGCCTCCTGTCCACGGATGCCTCCCACAGTCGGGGTAGCAGCTCCTCCTCACACAGCT 
P P G P P G P Q G P P G D S R L L 5 T D ASH S R G 5 S 5 5 5 H 5 5 
CATCTGTCAGGCGGGGCAGCTCCTACAGCTCTTCCATGAGCACAGGAGGAGGTGGTGCAGGCTCCCTGGGTGCAGGCGGTGCCTTTGGTGAAGCTGCAGG 
5 V R R G S 5 Y S SSM 5 T G G G GAG S L GAG G A F G E A A G 
AGACAGGGGTCCCTATGGCACTGACATCGGCCCAGGCGGAGGCTATGGGGCAGCAGCAGAAGGCGGCATGTATGCTGGCAATGGCGGACTATTGGGAGCT 
D R G P Y G T DIG P G G G Y G A A A EGG M Y A G N G G L L G A 
GACTTTGCTGGAGATCTGGATTACAATGAGCTGGCTGTGAGGGTGTCAGAGAGCATGCAGCGTCAGGGCCTACTGCAAGGGATGGCCTACACTGTCCAGG 
D FAG D L D Y N E L A V R V S E S M Q R Q G L L Q G MAY T V Q . O 
GCCCACCAGGCCAGCCTGGGCCACAGGGGCCACCCGGCATCAGCAAGGTCTTCTCTGCCTACAGCAACGTGACTGCGGACCTCATGGACTTCTTCCAAA'C 
P P G Q P G P Q G P P GIS K V F 5 A Y. 5 N V TAD L M D F F Q T 
TTATGGAGCCATTCAAGGACCCCCTGGGCAAAAAGGAGAGATGGGCACTCCAGGACCCAAAGGTGACAGGGGCCCTGCTGGGCCACCAGGTCATCCTGGG 
YGAIQGPPGQKGEMGT PGPKGDRGPAGPPGHPG 
CCACCTGGCCCTCGAGGACACAAGGGAGAAAAAGGAGACAAAGGTGACCAAGTCTATGCTGGGCGGAGAAGGAGAAGAAGTATTGCTGTCAAGCCGTGAG 
P P G P R G H K G E K G D K G D Q V Y A G R R R R R 5 I A V K P 
CTAGCCATGGCAGGACAGCTCCTGGACCAGGTCTCATAATGCATGTGGCACTTAGGTCCAAGGTCTCCA 4669 
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Figure 3. Nucleotide and deduced amino acid sequence of the human BP180 autoantigen. This nucleotide sequence, obtained from the set of over1apYh~ 
BP180 cDNA clones represented in Fig I, contains one long open reading frame encoding a polypeptide of 155 kD with an isoelectric point of ~.7. 'fhis 
putative transmembrane domain is indicated by the double lmderline. Shaded areas, collagen triple helical domains. The stop codon is marked with an astemk. 
sequence appears to be miss ing the 5' terminus of the BP180 coding region. 
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of Fig 7 show the immunoblot analysis of this epidermal extract 
after 10 min, 30 min, and 2 h of collagenase digestion, respectively. 
This time-course analysis shows the gradual disappearance of the 
180-kD band, the transient appearance of a 102-kD band, and fi-
nally a 97-kD collagenase-resistant polypeptide. All three of these 
bands exibited reactivity with serum BP-Rl, indicating that the two 
smaller polypeptides arose as a breakdown of the full-length BP180 
antigen. As further verification of the relationship between the 
180-kD and the 97-kD collagenase-resistant bands, rabbit anti-
serum, R22-31, was shown to react on immunoblot analysis with 
both of these polypeptides (Fig 7, lanes 6 and 7). A variety of controls 
Were used, as described in Materials and Methods, to demonstrate that, 
under the conditions of this assay, degradation of BP 180 was due to 
the action of the well-characterized Ca++-dependent bacterial col-lage~ase, and not due to the action of contaminating proteolytic 
actlV~ty. For example, replacement of the CaCI2 with EDTA in the 
re~ctlOn mixture resulted in an inhibition of digestion of the BP180 
epidermal antigen even after a 2-h incubation at 37°C with 1 BTC 
Unit of collagenase (Figure 7, lane 5). This result rules out the action 
of a Ca++-independent protease as a mechanism ofBP180 degrada-
tion In Our assay. Immunoblot analysis of this epidermal extract 
With a second BP serum, BP-Cl (which reacts strongly with the 
BP230 antigen) revealed that BP230 remained intact after a 2-h 
~reatment with 1 BTC unit of collagenase at 37°C in the presence of 
puffe~ TBSC, which contains 10 mM CaCI2 (data. not shown). 
OSltlve and negative controls included PAGE analysls of collagen-
ase digestions of type I calf skin collagen, BSA, and bovine muscle 
mYOSI11. 
DISCUSSION 
iirculating autoantibodies from BP patients have previously been 
s OWn to bind hemidesmosomal antigens of squamous epithelia 
[4-7] and to react, by immunoblotting and immunoprecipitation, 
~Ith two large eyidermal proteins, designated as the BP230 and 
hP180 antigens [10-12]. Our laboratory has previously reported 
t e characterization of a human epidermal cDNA encoding a por-
tion of the BP180 autoantigen using a human BP serum, BP-Rl 
[15]. The present report describes the isolation and sequence analy-
sl: of a series of overlapping cDNA clones that spans 4,669 bases of 
t e BP180 transcript. 
I' The contiguity of the BP180 cDNA was established using several 
~nes of evidence. First, the cDNA stretch corresponding to nucleo-
t;de numbers 1 to 2679 is represented in multiple independent 
b ones. Second, the cD N A stretch corresponding to nucleotide num-
ers 1312 to 4600 shows a high degree of homology, both at the 
nUcleotide and the amino acid levels with a chick cornea cDNA s~quence reported by Marchant et al [30] . Finally, the contiguity of k; BP180 clones was confirmed by PCR analysis. Us~ng 
43180-specific primers, overlapping cDNA segments spanmng 
cD 87 b~ses of the BP180 transcript were PCR-amplifie? ~rom a 
f NA hbrary unrelated to the libraries from which the ong1l1al set 
o ~P.180 clones was isolated. 
his cloned portion of BP180 was shown to contain one long 
open reading frame encoding a 155-kD polypeptide. It is not yet 
BP180 Tandem Repeats 
Figu 
of th re 4. Alignment of BP180 tandem repeats. Four contiguous stretches 
can e BP180 protein sequence from residue 262 through 359 exhibit signifi-
sub t sequence similarities. Shaded areas, positions of identity or conservative 
Stltutions, as defined by Bordo and Argos [41] . 
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clear whether this stretch encompasses the entire BP180 coding 
region. Contained within this cloned segment was an in-frame stop 
codon at position 4597 - 4599. The first in-frame AUG codon ap-
pears at position 106-108; however, this is not likely to be the 
translation initiation site because of the presence of an out-of-frame 
AUG sequence at position 101-103. Repeated attempts to isolate 
additional cDNA clones containing sequences upstream of our 5'-
most clone, clone 262-F, have been unsuccessful. Identification of 
the N-terminus ofBP180 via protein microsequencing has thus far 
been precluded due to the lack of an optimal source for the isolation 
of sufficient quantities of this protein. 
Analysis of the BP180-deduced amino acid sequence identified a 
single, putative membrane-spanning domain at amino acid position 
502-524, which has the potential to function as a signal-anchor 
sequence for a type II transmembrane protein (see below). The 
polypeptide segment on the N-tenninal side of this putative trans-
membrane domain is highly basic (pI of this 501 amino acid stretch 
is 10.37, whereas the pI of amino acids 1- 229 is even higher, 11.34) 
and was shown to contain a degenerate set of four 24 - 26 residue 
tandem repeats. The relevance of these repeats remains undeter-
mined. Comparison of the nucleotide and amino acid sequences of 
this putative intracellular segment ofBP180 with the entries of the 
GenBank and EMBL nucleotide sequence data bases and the Swiss 
protein sequence data base revealed no significant homologies. 
The most striking structural feature of the BP180 protein is the 
long C-terminal collagenous region. This stretch of alm'ost 100 kD 
is made up of 15 domains of variable size that are predicted to form 
collagen-like triple helices interrupted by segments of non-collagen 
sequence. We propose that the collagen domains (COLl through 
COLl5) and the non-collagen domains (NCl through NC16) be 
numbered starting at the C-terminus. Domain NC16, which en-
compasses the membrane-spanning domain, has been further subdi-
vided as follows: NC16a corresponds to that portion lying to the 
C-terminal side of the transmembrane domain (designated 
NC16b), whereas the remaining N-terminal segment is labeled 
NC16c (see Fig 5) . This sequence analysis predicts BP180 to be a 
transmembrane protein with a type II orientation, i.e., the C-ter-
minal collagenous region positioned externally, as represented sche-
matically in Fig 5. This transmembrane orientation has been sup-
ported by recent ultrastructural localization studies using antibodies 
generated against two BP180 recombinant proteins corresponding 
to portions of the predicted cytoplasmic and ectodomains [31] . 
The C-terminal 1,098 amino acids of BP180 exhibit a particu-
I 1 
o 30~ 
I I 
Collagenous 
Region 
600 900 1200 
Amino Acid Number 
1500 
Figure 5. Schematic representation of the domain organization of the 
human BP180 antigen. The putative membrane-spanning domain is desig-
nated by the opw oval. The C-terminal 1007 amino acid stretch is shown as 
an extracellular domain that is predicted to extend into the basal lamina 
region adjacent to the basal keratinocyte. This C-terminal region consists of 
a series of 15 co!lagen domains (COlt through COltS; solid boxes) and 
stretches of non-collagen sequence (NC1 through NC16a; t/rill litles). Num-
bering of both the collagen and non-collagen domains starts at the C-ter-
minus. The non-collagen domain, NC16, encompasses the membrane-
spanning domain, NC16b, as well as flanking regions to the C-terminal and 
N-terminal sides (NC16a and NC16c, respectively). Domain NC16c, the 
N-terminal segment predicted to be an intracellular domain, includes the 
four tandem repeats (shown in Fig 4 and indicated here as solid ovals) . 
248 GIUDICE ET AL 
HUM SGLKAEIUfGDLKTVSTKGKTT'I'I\DIHSYSSSGGGOSGGGGGVGOAGGOPWGPAPAWCPCOSCCSWWKWLLGLLLTWLLLL 
.. .. .. .. .. :.... .... :::::. ::: :::::::::: : ::::::: : ::::: 
CUK PGLKSDIlNGGLRSAPTRDKATYAEIQN---------------GGAGOAI .GSAPSWCPCGSCCSWWKWLLGLLLAWLLLL 
HUM GLLFGLI1lLAEEVRKLKARVDEL£RIRRSILPYGDSMDRIEKDR-----LQGMAPMGADLDKIGLBSDSQEELWMFVRK 
CDK GLLFGLIIlLAEEVRKLKSRVDNLEKINlI SFLTVNQGNPYLEKDVSKVDFLHGVAPSS-------TFPFENEESVWLMVKS 
HUM KLMMEQENGNLR---GSPGPKGDMGSPGPKGDROFPOTPGIPGPLGBPGPQGPKGQKGSVGDPGMEGPMGO'RGR.EGPMGP 
• : • • • • : " J It" : 1 If' : I 1 • 1 It' l I 1 I • f' I) . ~ t t , f ; 1 1 • 1 , If' , 1 I I f I f I 1 1 I I I 
CUK RLNKEIERGYFROERGEPOMXGDMGLQOPItGDRGLPOVPGIPGPVOHQGPEOPKGQ:KGSMODP?M~GPM~~GR~OLPOP 
IfUM ROE~OPPGSOEKOEROl\AGEPOPROPPGVPosVapJ(GS80SPGPQGPPOPVGLQOLROEVGLPOVl:GDKOpMOPPGPKOO 
: : = . I f ; : :: 1 I • : : • : ::: : : ~ t :: : :: : ! : : : t : t : !: :: f : : • , :: t t :: ::.::. :: : : I : : ; 
CHK ROEPOPPGFOEKGDRGPAc---OPPGPPOprGSAGLKOP~GSPo.Poa~p_9~~aLQGP'c.~..9~<;J~PG~o.,~ItG1crO!POPKGO 
HUM QGEKopnOLTGEPoMitGLPGAVOEPG~KOMtOPAGPDOBQ;GPRGEQOLTGMPOIRapPG~SODPGKPGLTOPQGPQOLPO 
I : : : : • . :.::: : :1 .: :. , :::: t :. : It ft. : ttt :::.:: :::::::,; : :ttt,::':: :t:: 
CHK OGEKG1UJGMTOEQGSRGIPOPPGEPOAKGPAOQAOR.DGQPOER~EPG~OIPGAR~F~OPSGDroEPOL'l'GPOGPPOLPG 
IItIM TPORPGIKGEPGJlPOKIVTSEGSSMLTVPOPPOPPGAHGPPGPPOAPGPAGPAGLPGDQ----------EVL--------
I t f tt Jl l t e Dlt : •. :: :: • • : tlJlttf •• t l ttft tllttl:"I.1 
CUK NPORPGAKOEPGAPGKVISAEGSSTIALPGPPGPPGPIGPTGPPGVP,GPVOPAOLPOQQOPRGEKGSAVEVVIETIKTEV 
IIUM __ _______ NLQGpPGPPCPRGPPGP S IPGPPOPROPPG_EGLPGPPGPPGSFLS NS ETrLFGPPGPPGPPGPKODQGPP 
• : :: • J tI t t : ) t t f. : J I r t : : , 1 r : 1 1 J ~ It t .: ::::. II t I r t il J J I I r : I : 1 I 
CUK SS LJ\ SQMLSDLQGRAOPPGPPGPPOESVQGLPQPRG~PGLPGPSGPPGRPGSSVSTSETFVS?PPO~PGPPOPKGDQGEP 
HUM GPR---GII90eQ<JLPGY9TSGSSSFOLNLQGPPOPPOPQGPKdDKaDPOVPOALGtP~GPGEGCSSSTMYVS_OPPOPPOP 
It : : : ; ::: : r : : . . . : -;:1;:;:;:: : : :.:1::: ; :; , S I ::: .I:tl : ::: 
CHK OPROP'TOEPGEPOL.PO"SsnOG---TVTMQOPPOPPoPPgP :.--KODJ\O":~O~.OlP-GrSROOSRQ---IQGP~GPPOP 
HUM POPPGs r SSSGQE IQQYIS EYMQS DSIR S YLSOVQOPPGPPOPPGPV'rTITGETFDYSE.LASHVVSYLRTSOYGVSLFS S 
.. ... . ::. :: :::: .. :. : : . : : : '::::1:::::::: .:: I : . ::: .:.::. 
CIIK PGPPOPQOSSSQE IQQYVADYLKSDNVRlfYLTGVQGPPOPPOPPOILTTADGKNF'DFAELATRVMSYVTSS S DllYQS F'Jl.S 
tlUM S I SS - - - - -ED ILA VLQRDDVRQYLRQ'lLMGPRGPPGPPOASGDGSLLS LDYAELSSRILSYMSSSG IS IGLPOPPGPPO 
•• • • • • : . : ::.. . : :::.t:: t t:litt , .11 : : :: : :: : •• : : . :::. :: :I:",llt: 
CtiK S VS TTS VLYQELLNMLQREEI----RQYLVOPROPPOPPGPOVDOMSLSLDYDELTRRFISYLTSSGHSIOLPGPPOPPO 
HUM LPOTS YEELLSLLROS EFRGIVGPP- ::'-GPPOPPGIPGNVWSSI S VEDLS S YLHTAGL S FIPGPPOPPGPPOPRGPPGVS 
I I I:: : : : I: : I.tttl 11"111Itt : . : .::. : I:. ::: :' IJllttt: tIll t 
CIIK 'rPGt8YSELTAYLRHSEFSOLVGPPOPAGP~GPPGtPo--SSO'l'8LEDISAYLQSVGYSSISpI2G~~OPPGPPOPPGFS 
HtIM a-ALATYAA-ENS DS FR S ELI S YLTSPDVRS FIVGPPQPPGPQGPP---ODS,RLLSTDAS---HSROSSSSSHSSSVRRO 
• •• • • • : : :: : ::: : : : .:::. : :: z ~ :,: : t t ; : f : . : : : : • • : • • 
CUK GTOLLSYADITUSDEF'RSELIQYLKSOEVRSYISOPPGS_~~!.?OP~G~KODSO:~VAGSMSSLYHOSLASERLHGOSIOAE 
UUM SSYSSSMSTGGOOAOSLGAG:"OAFGE~OORGPYGTDIOPGGGY-OAA-AEGG--MYAGNGOLLOADFAODLDYNELAVR 
. : •• : . • •••. : •• • • •• ; 11: ., 1.: : : . . . : : : : :1: : : . 
CHK GS IlOOSLGAT SS YGS S MSSSMSS YS ASMOSDGSYOASVGS DGS FDGLLTAEES fiRRS AOPORSYSSSFTOSLDYNELARfi 
HUM VSES MQRQOLLQO-MAYTVQGP POQPGPQGPPGISKVF S AYSNVTADLMDFFQTYGAIQGPPOQKOEMOTPOPKGDROPA 
• . • • : : : :. : : : ::* l l '(( Itll".: : ::. : :: I: : ::: : : • :':11.1" : JIll"~ :: 
CHK VS ENLQS RGILQDLMS YT GQGPPGPPOPPGPPOISRVFA1\YGNVTEDLMDFF'RTHGTVRGPPGBXOERGYPGPKGDPGPN 
DUM GPP~iiPGPPGPROJiJtGEXO-oK;;"- :';;:';;;"ODO---VYAGRRRR---R--SIAVKP 
· ... : .. .. ' : . : .: : :.: 
CUR G-Pprrn,O~qDQRErutARKVNKCIVAEGEEEALQFKORAKSVLYRAASLAAQR 
Figure 6. Alignment of the amino acid sequences deduced from the human 
BP180 cDNA and a chick cornea collagen cDNA [30]. The region of over-
lap corresponds to amino acid positions 435 to 1532 of the human sequence. 
These two sequences exhibit 64% identity and 78% similarity. Optimal 
alignment was obtained by the Bestfit program of the GCG software pack-
age [26]. Identical residues are indicated by a double dot and similar residues by 
a single dot. Note the high degree of conservation of the sizes and positions of 
the collagen domains designated by the shaded boxes. 
lady high degree of similarity with a recently reported sequence 
obtained from a chick cornea eDNA [30]. These structural similari-
ties strongly suggest that these two proteins are human and chicken 
homologues. The short gaps that were present in the human and 
chick protein alignment probably represent inter-species diver-
gence; however, because these two eDNA segments originated 
from different tissues (human epidermis and chick cornea), the ob-
served divergence could alternatively be due to the existence of 
tissue-specific BP180 isoforms. A related issue that remains to be 
resolved is whether the human BP180 antigen (or an isoform) is a 
component of the hemidesmosomes of cornea or other stratified, 
squamous epithelia, as has been shown to be the case in human 
epidermis [15]. No data have yet been reported concerning the 
transmembrane nature or the ultrastructural localization of the 
chick cornea protein. . . 
As a means of independently demonstrating the presence of colla-
gen-like sequences within the BP180 autoantigen, a human skin 
extract was treated with collagenase from Clostridium histolyticum 
and the digestion products were subsequently analyzed by SDS-
PAGE and immunoblot. Detailed characterization of the substrate 
specificities of the collagenases from this bacterium has been 
previously reported [32 - 35], and has allowed for the identification 
of potential collagenase-sensitive sites on BP180. Based on this 
analysis it was predicted that complete collagenase digestion of the 
BP180 antigen would result in the degradation of the C-terminal 
87-kD segment of this protein to small peptide fragments. The 
experimental results coincided quite well with this prediction. Col-
lagenase treatment of the epidermal extract resulted in specific deg-
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radation of approximately 83 kD of the BP180 antigen, generating 
one major collagenase-resistant, autoantibody-reactive peptide of 
97 kD. These results verify the existence of a large collagenoUS 
region on the 180-kD human epidermal BP antigen. 
The results of the above immunoblot analysis also demonstrate 
that an epitope recognized by BP-Rl autoantibodies is located 
within the 97-kD collagenase-resistant fragment of BP180. ThiS 
finding is consistent with results previously reported by our group 
[36]. In this earlier study a BP autoantibody-reactive epitope waS 
shown to be located within the major collagenase-resistant frag-
ment of the protein encoded by clone ABP180-22A. The epitope-
bearing segment of this recombinant form ofBP180, a stretch t.hat IS 
also predicted to be present within the 97 kD collagenase-resistant 
BP180 fragment, has recently been further characterized by epltope 
mapping and ultrastructural immunolocalization analyses. !" major 
antigenic site recognized by autoantibodies from BP patients, as 
well as from patients suffering from herpes gestationis (a clmlcaIly 
related subepidermal dermatosis of pregnancy), was shown to ~e 
restricted to a 14 amino acid segment located in the N C 16a domain 
(between the putative transmembrane domain and the collagenoUS 
BP-R1 R22-31 
o 10' 30' 2h 2h l' 1h 
180" 
1 2 3 4 5 6 7 
Figure 7. Immunoblot analysis of a human epidermal extract treated wi~~ 
bacterial collagenase. A human epidermal extract containing the .BP1 _ 
antigen was subjected to collagenase digestion and the products v:ere fr~'r 
tionated by SDS-PAGE, blotted to nitrocellulose, and labeled With e('t ~ 
serum BP-Rl, a well-characterized BP serum that recognizes BP180 alhe 1-5), or with a rabbit antiserum, R22-31, which was prepared agaillst the 
p-galactosidase-BP180A fusion protein (latles 6 and 7) . The numbers to t 1 
left of the figure indicate apparent molecular weight (in kD). La lies of 
through 4 show the results of a time course of digestion with 1 BTC ut.~e 
collagenase at 37°C in the presence of 10 mM CaClz for the length 0. t1ly). indicated at the top of each lane (0, 10 min, 30 min, and 2 h, respective eS 
BP180, identified as the 180-kD antigen in the untreated extract, underg~at 
digestion to a 102-kD intermediate (lane 3) and a97-kD fragment t"Il 
remams after complete collagenase digestIOn (2-h time pomt, lane 4)·f\l1TI 
three bands (180 kD, 102 kD, and 97 kD) exhibited reactivity With se fS Z 
BP-R1. An immunoreactive band with an apparent molecular weight °d by 
kD is seen in lanes 1 through 4. This polypeptide, which was unaffecte the 
the collagenase treatment, is of unknown relevance. Lane 5 shoWS ase 
immunoblot result of the same epidermal extract after a 2-h collagenrial 
treatment in the presence of 75 mM EDTA (an inhibitor of the bacte eOt 
collagenase). No digestion of BP180 was detected. Lanes 6 and 7 rC!:re\he 
immunoblots of the epidermal extract treated with collagenase III ndy 
presence of CaClz for 1 min and 60 min, respectively, and sub~equef\lIl_ 
labeled with rabbit antiserum, R22-31. This antiserum recognizes ent 
length BP180 (lane 6) and the 97-kD collagenase-resistant BP180 fragm 
(lane 7) . 
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region)* [37]. Furthermore, these studies have localized this epi-
to~e-bearing domain of BP180 to the extracellular region of the 
epidermal hemidesmosome* [31]. These results are consistent with 
OUr predicted type II transmembrane orientation of BP180. 
. Based on the structural analysis presented in this report, BP180 
IS predicted to be an integral membrane protein that, in the sim-
plfst case, associates with two other polypeptides to form an extra-
ce lular collagen triple helix. This remarkable combination of 
shructural features has only been found in two other proteins, 
~ e type I and type II macrophage scavenger receptors [38,39]. 
doth ?f th.ese closely related proteins have a singl~ transm~mbrane 
Bomal11 With the same uncommon type II orientation predicted for 
P180. Such proteins have a signal-anchor sequence in lieu of an 
bml11o-terminal signal peptide [40]. The extracellular region of 
ot.h forms of the macrophage receptor contains a coiled coil do-
lllain and a collagen triple helical domain. In addition, this C-ter-
llllUal ectodomain has been shown to function in cell-ligand inter-
actions [39] . More detailed analyses reveal limitations in the 
structural similarities between BP180 and the macrophage recep-
~ors. These proteins share no significant sequence homology except 
or. the regularly spaced glycine residues within the collagenous 
regions. The NC16a domain of BP180, the segment that corre-
sponds in position to the coiled coil domain of the macrophage 
scavenger receptors, has only a very short stretch with the primary 
structural features consistent with a coiled coil structure. 
In summary, this molecular analysis of the BP180 antigen has 
}evealed several structural features that suggest that this protein may 
. Unction as a cell-matrix adhesion molecule. BP180 appears to be an 
Ihtegral membrane protein with a localization pattern restricted to 
~oe hemide.smosomes of stratified, squamous eP.ithelia. T~e car-
xyl-termmal half of BP180 is made up of multiple domams that 
~onfain the basic structural requirements for forming collagen-like 
np e helices. This collagenous region of BP180 is predicted to be 
an extracellul ar domain that may function as a site of interaction 
;lth an extracellular matrix component, stabilizing the dermal-epi-
ehlllal association. Disruption of such an adhesive interaction, via elt erautoantibody reactivity (as in the case ofBP or HG) or genetic 
rnu~at~on (as in certain genodermatoses, such as junctional epider-
rnb YSls bUllosa), may playa critical role in the pathogenesis of these 
su -epidermal blistering disorders. 
------------------------------------------------~ Would like to ackllowledge the advice and support oj Jallet A. Fairley, M.D. 
theepartll~elll oJDermatology, MCW) alld LialleMetlde-},tftleller, ph.D., directoroJ 
~"'/Ntlcleic Acid Shared Facility at MCW. 
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